利用功能性注释来绘制与阿尔茨海默病相关的罕见变体的地图
Anjali Das1,2, Chirag Lakhani2, Chloé Terwagne3
1Computer Science, Columbia University, New York, NY, USA.
medRxiv : the preprint server for health sciences
|December 16, 2024
概括
我们开发了 gruyere,这是一个新的贝叶斯模型,用于分析全基因组测序数据,以找到与阿尔茨海默病等复杂疾病相关的罕见变异.
科学领域:
- 基因组学就是基因组学.
- 计算生物学 计算生物学
- 神经科学是一个神经科学.
背景情况:
- 全基因组测序 (WGS) 能够研究复杂疾病中的罕见变异 (RV).
- 现有的RV关联测试通常使用每基因模型,并未充分利用功能注释.
- 罕见的非编码变异,特别是在微质细胞中,与阿尔茨海默病 (AD) 风险有关,但难以分析.
研究的目的:
- 介绍格鲁耶,贝叶斯模型通过学习特征特定的功能注释权重来优先考虑RVs.
- 通过结合非编码RVs的细胞类型特定功能注释来增强AD遗传关联研究.
- 使用WGS数据识别新的AD相关基因和功能注释.
主要方法:
- 开发了格鲁耶,一个贝叶斯概率模型用于全基因组罕见变异丰富分析.
- 在阿尔茨海默氏病测序项目的WGS数据 (7,966例,13,412对照) 上应用了格鲁耶.
- 使用微质和其他脑细胞类型中预测的调节元素定义的非编码RV测试集.
- 纳入细胞类型特定变异效应预测 (VEP) 作为功能注释.
主要成果:
- 格鲁耶尔确定了15个重要的AD遗传关联,这些关联在其他RV方法中没有发现.
- 基于深度学习的VEP用于拼接,转录因子结合和染色质状态准确预测功能性非编码RVs.
- 该模型成功地集成了编码RV,功能注释和特定细胞类型的非编码RV.
结论:
- 格鲁耶为罕见变异的全基因组关联测试提供了一个强大的框架.
- 这项研究强调了功能注释和细胞类型特定的调控元素在理解AD遗传学的重要性.
- 这种方法揭示了新的AD相关基因和注释,推动了复杂疾病的研究.
更多相关视频
相关概念视频
Genome-wide Association Studies-GWAS
12.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.4K
Alzheimer's Disease: Overview
444
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
444


